| A new equation to estimate glomerular filtration rate | Annals of Internal Medicine | 2009 | 13.9K |
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Annals of Internal Medicine | 1999 | 11.2K |
| Prediction of creatinine clearance from serum creatinine | Nephron | 1976 | 10.7K |
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | New England Journal of Medicine | 2004 | 8K |
| Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group | Critical Care | 2004 | 4.5K |
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | New England Journal of Medicine | 2001 | 4.4K |
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Annals of Internal Medicine | 2006 | 3.8K |
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | New England Journal of Medicine | 2014 | 3.3K |
| A model to predict survival in patients with end-stage liver disease | Hepatology | 2001 | 3.3K |
| Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship | Clinical Infectious Diseases | 2007 | 2.8K |
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | New England Journal of Medicine | 2001 | 2.5K |
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention | Circulation | 2003 | 2.5K |
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Journal of Hepatology | 2012 | 2.5K |
| Clinical epidemiology of cardiovascular disease in chronic renal disease | American Journal of Kidney Diseases | 1998 | 2.5K |
| Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes | New England Journal of Medicine | 2019 | 2.5K |
| Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery | Lancet, The | 2005 | 2.3K |
| International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma | Lancet Oncology, The | 2014 | 2.3K |
| New equations to estimate GFR in children with CKD | Journal of the American Society of Nephrology: JASN | 2009 | 2.2K |
| Assessing kidney function--measured and estimated glomerular filtration rate | New England Journal of Medicine | 2006 | 2.1K |
| Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney International | 2005 | 2.1K |
| Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction | New England Journal of Medicine | 2019 | 2K |
| Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes | New England Journal of Medicine | 2016 | 2K |
| Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients | Critical Care Medicine | 2002 | 1.9K |
| American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults | Journal of the American Geriatrics Society | 2015 | 1.8K |
| Advanced glycation end-products: a review | Diabetologia | 2001 | 1.8K |
